ArticleBMC cancer2022

Nanoparticle albumin-bound paclitaxel and PD-1 inhibitor (sintilimab) combination therapy for soft tissue sarcoma: a retrospective study.

Zhichao Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.